FDA removes black box warning from menopause hormone therapies: What this will mean

In a major shift, the FDA announced it will remove long-standing black box warnings from hormone-based treatments for menopause symptoms like hot flashes. The agency now says new data show limited risks for women who begin therapy before age 60 or within a decade of menopause. FOX 5 NY’s Antwan Lewis explains how the reversal could change medical guidance and help reduce the stigma surrounding hormone replacement therapy.